Recovery of a triazole-resistant
Aspergillosis
COVID-19
Coronavirus
ICU
SARS-CoV2
Triazole-resistance
Journal
Medical mycology case reports
ISSN: 2211-7539
Titre abrégé: Med Mycol Case Rep
Pays: Netherlands
ID NLM: 101598259
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
29
05
2020
revised:
30
06
2020
accepted:
30
06
2020
pubmed:
25
8
2020
medline:
25
8
2020
entrez:
25
8
2020
Statut:
ppublish
Résumé
Although invasive pulmonary aspergillosis (IPA) is typically described in immunocompromised host, patient with severe influenzae can develop IPA. Similarly, patients with severe COVID-19 complicated with IPA are increasingly reported. Here, we describe a case of invasive aspergillosis with triazole-resistant
Identifiants
pubmed: 32837880
doi: 10.1016/j.mmcr.2020.06.006
pii: S2211-7539(20)30043-9
pmc: PMC7331532
doi:
Types de publication
Case Reports
Langues
eng
Pagination
15-18Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
There was no funding for this manuscript. All authors declare that they have no conflicts of interest regarding this manuscript.